Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis: Part A
Authors:
- Ivo A. WiertzIWIvo A. Wiertz
- Sofia A. MollSofia A. Moll
- Benjamin SeeligerBSBenjamin Seeliger
- Nicole P. BarloNBNicole P. Barlo
- Joanne J. van der VisJVJoanne J. van der Vis
- Nicoline M. KorthagenNKNicoline M. Korthagen
- Ger T. RijkersGRGer T. Rijkers
- Henk J.T. RuvenHRHenk J.T. Ruven
- Jan C. GruttersJGJan C. Grutters
- Antje PrasseAPAntje Prasse
- Coline H.M. van MoorselCMColine H.M. van Moorsel
Open Access
- 21 June 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (6) , 1940
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disease, characterized by fibroblast proliferation and extracellular matrix deposition. CC-chemokine ligand 18 (CCL18) upregulates the production of collagen by lung fibroblasts and is associated with mortality. This study was designed to evaluate the influence of single nucleotide polymorphisms (SNPs) in the CCL18 gene on CCL18 expression and survival in IPF. Serum CCL18 levels and four SNPs in the CCL18 gene were analyzed in 77 Dutch IPF patients and 349 healthy controls (HCs). CCL18 mRNA expression was analyzed in peripheral blood mononuclear cells (PBMCs) from 18 healthy subjects. Survival analysis was conducted, dependent on CCL18-levels and -genotypes and validated in two German IPF cohorts (Part B). IPF patients demonstrated significantly higher serum CCL18 levels than the healthy controls (p < 0.001). Both in IPF patients and HCs, serum CCL18 levels were influenced by rs2015086 C > T genotype, with the highest CCL18-levels with the presence of the C-allele. Constitutive CCL18 mRNA-expression in PBMCs was significantly increased with the C-allele and correlated with serum CCL18-levels. In IPF, high serum levels correlated with decreased survival (p = 0.02). Survival was worse with the CT-genotype compared to the TT genotype (p = 0.01). Concluding, genetic variability in the CCL18-gene accounts for differences in CCL18 mRNA-expression and serum-levels and influences survival in IPF.Keywords
Funding Information
- ZonMW TRopZorg St. Antonius Care Grant (842002001)
- ZonMW TopZorg St Antonius research grant (842002003)
This publication has 31 references indexed in Scilit:
- CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseasesRespiratory Medicine, 2013
- Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosisEuropean Respiratory Journal, 2011
- Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transductionClinical Immunology, 2010
- Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary FibrosisChest, 2009
- Expression of chemokine (C–C motif) ligand 18 in human macrophages and atherosclerotic plaquesAtherosclerosis, 2009
- CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosisArthritis & Rheumatism, 2007
- Genetic Variation in the CCL18-CCL3-CCL4 Chemokine Gene Cluster Influences HIV Type 1 Transmission and AIDS Disease ProgressionThe American Journal of Human Genetics, 2006
- Serum pulmonary and activation‐regulated chemokine/CCL18 levels in patients with systemic sclerosis: A sensitive indicator of active pulmonary fibrosisArthritis & Rheumatism, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001